It has also been reported that high levels of GOLPH3 protein enhance the frequency of cell death in rapamycin-treated melanoma cells, suggesting that GOLPH3 expression can be used to predict rapamycin sensitivity in tumor therapy [5]. This evidence concerns the gene GOLPH3 and neoplasm.